Global Optogenetics Market Is Estimated To Witness Growth Owing To Increasing Prevalence Of Chronic Diseases And Growing Patient Population

Optogenetics Market
Optogenetics Market

Overview:

Optogenetics is a way of controlling brain cells with light. It is a combination of genetics and optical technologies that allows scientists to switch specific neurons on or off precisely and selectively. It is a powerful tool for studying neuronal activity in living animals and it can be used to understand certain neurological diseases.

It has the potential to be useful in the treatment of vision loss, deafness, and pain in humans. These genes are incorporated into the cell membranes of neurons and allow the cells to be turned on or off with light. These tools can be used to control neuronal activity in the context of a wide variety of questions, ranging from understanding the mechanisms that regulate fear to exploring how dopamine-making neurons may give rise to feelings of reward and pleasure.

Market Dynamics:

Growing acquisition by key players is estimated to augment growth of the global Optogenetics Market over the forecast period. For instance, Arctos Medical was acquired by Novartis in September 2021. This acquisition will enhance their optogenetics portfolio and also bring in new treatments for patients suffering from serious vision loss. Moreover, lack of awareness regarding optogenetics is anticipated to restrain growth of the global optogenetics for market over the forecast period.

Impact of COVID-19:

The pandemic had a significant impact on many sectors of the society. The pandemic had a major impact on the manufacturing of several items as several units were halted. This was due to shortage of raw materials and skilled manpower. The pandemic also had a huge impact on the healthcare system of many countries.

Several nations were facing challenges in treating COVID-19 patients as there was a shortage of drugs, medical equipment and skilled professionals. During the pandemic many research activities and clinical trials were also stopped, owing to strict government restrictions and many other research activities were being conducted for developing vaccines and drugs against COVID-19. This hampered the growth of the global optogenetics for market.

Key Takeaways:

The global Optogenetics Market is expected to witness high growth, exhibiting CAGR of 17.35%  over the forecast period, due to growing expansion by key players.

For instance, TSE Systems and NeuroLux, declared their partnership in September 2021, that will help in changing the in vivo animal science. North America is anticipated to witness significant growth in the global optogenetics for market over the forecast period, owing to growing prevalence of chronic diseases and rising product launches.

Major players operating in the global Optogenetics Market are Thorlabs Inc., Hubner Group, Shanghai Laser & Optics Century Co. Ltd, Coherent Inc., Noldus Information Technology, Gensight Biologics, Prizmatix, Laserglow Technologies, Judges Scientific plc, Elliot Scientific Limited, Addgene, Merck KGaA, Danaher, and Bruker.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more